TY - JOUR
T1 - Innovating medication reviews through a technology-enabled process
AU - Thiruchelvam, Kaeshaelya
AU - Byles, Julie
AU - Hasan, Syed Shahzad
AU - Kairuz, Therese
N1 - Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2022/4/1
Y1 - 2022/4/1
N2 - Medication reviews are effective in improving the quality of medication use among older people. However, they are conducted to various standards resulting in a wide range of outcomes which limit generalisability of findings arising from research studies. There also appear to be funding and time constraints, lack of data storage for quality improvement purposes, and non-standardised reporting of outcomes, especially clinically relevant outcomes. Furthermore, the coronavirus disease-19 (COVID-19) pandemic has restricted many face-to-face activities, including medication reviews. This article introduces a technology-enabled approach to medication reviews that may overcome some limitations with current medication review processes, and also make it possible to conduct medication reviews during the COVID-19 pandemic by providing an alternate platform. The possible advantages of this technology-enabled approach, legislative considerations and possible implementation in practice are discussed.
AB - Medication reviews are effective in improving the quality of medication use among older people. However, they are conducted to various standards resulting in a wide range of outcomes which limit generalisability of findings arising from research studies. There also appear to be funding and time constraints, lack of data storage for quality improvement purposes, and non-standardised reporting of outcomes, especially clinically relevant outcomes. Furthermore, the coronavirus disease-19 (COVID-19) pandemic has restricted many face-to-face activities, including medication reviews. This article introduces a technology-enabled approach to medication reviews that may overcome some limitations with current medication review processes, and also make it possible to conduct medication reviews during the COVID-19 pandemic by providing an alternate platform. The possible advantages of this technology-enabled approach, legislative considerations and possible implementation in practice are discussed.
KW - Computerised decision support system
KW - Innovation
KW - Medication reviews
KW - Technology
UR - http://www.scopus.com/inward/record.url?scp=85111267393&partnerID=8YFLogxK
U2 - 10.1016/j.sapharm.2021.07.019
DO - 10.1016/j.sapharm.2021.07.019
M3 - Review article
VL - 18
SP - 2700
EP - 2705
JO - Research in Social and Administrative Pharmacy
JF - Research in Social and Administrative Pharmacy
SN - 1551-7411
IS - 4
ER -
